Výsledky vyhledávání

Abstract P3-09-19: A prospective study of fertility preservation by controlled ovarian hyperstimulation (COH) without letrozole in young breast cancer patients before adjuvant chemotherapy: Preliminary results

Autor: C Decanter, A Govaere, J. Bonneterre, Audrey Mailliez, S Jebert, Y Vendel

Publikováno v: Cancer Research. 73:P3-09

Background: 6300 new cases of breast cancer arise in young women under 40 each year in France. The majority receives chemotherapy and a lot of them have not completed their family. The incidence of persistent chemotherapy-induced amenorrhea in these

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::89c5058367bbe3b037d1ed487dc10da1
https://doi.org/10.1158/0008-5472.sabcs13-p3-09-19

Zobrazit plný text záznamu

Abstract P2-13-10: Prospective randomized and multicentric evaluation of cognition in menopausal breast cancer patients receiving adjuvant hormonotherapy: a phase III study (Preliminary results)

Autor: L Vanlemmens, X Delbeuck, V Servent, A Mailliez, C Lefeuvre-Plesse, P Kerbrat, T Petit, C Fournier, Y Vendel, S Clisant, J Bonneterre, F Pasquier, Rhun E Le

Publikováno v: Cancer Research. 72:P2-13

Background: Cognitive impairment has been considered to be a possible adverse effect of aromatase inhibitors (AI). The aim of the study was to compare the impact of tamoxifen or AI on verbal memory (Rey auditory-verbal learning test) and other cognit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::812d06f1855e7e352bdb1fd0e9ef88fd
https://doi.org/10.1158/0008-5472.sabcs12-p2-13-10

Zobrazit plný text záznamu

Prognostic factors for cancer patients with good performance status considered for inclusion in phase I clinical trials

Autor: M. E. Bonneterre, M. Degardin, Eric Dansin, R. Beuscart, Antoine Adenis, Y Vendel, Stéphanie Clisant, Nicolas Penel, Jacques Bonneterre, Marie Vanseymortier

Publikováno v: Journal of Clinical Oncology. 25:2568-2568

2568 Background: For investigators, the selection of patients to be considered for phase I clinical trials is difficult, because of the lack of objective criteria for a rational decision-making process. From October 1997 to October 2002, we retrospec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7f43c7d9672885b91bebc866e53da306
https://doi.org/10.1200/jco.2007.25.18_suppl.2568

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání